Furthermore, by using a mouse model of genetically induced breast cancer, the reduced expression of CAV-1, associated with elevated SOD-2 and enhanced AMPK activation, was also confirmed in tissue sections from mammary tumors but not in their healthy counterparts. The gene discussed is SOD2; the disease is breast cancer.